JBIO
Jade Biosciences
$19.95
−$0.13 (−0.65%)Jul 27, 2026
Key metrics
The numbers that frame JBIO today
- Market cap
- $984.73M
- P/E (TTM)
- -7.6
- EV / FCF
- -8.0
- ROIC
- -86.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $6.67
- 52wk High
- $27.96
Growth
Revenue and earnings trend for JBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about JBIO
Is Jade Biosciences a good buy?
Hold. Jade Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Jade Biosciences is selling at a very high price.
What is the market capitalization of JBIO?
Jade Biosciences's market capitalization is $984.73M.
What is the P/E ratio for JBIO stock?
Jade Biosciences's current P/E ratio is -7.6.
What is the 52-week high for JBIO stock?
The 52-week high for Jade Biosciences is $27.96. The current close of $19.95 is 28.6% below that high.
What is the 52-week low for JBIO stock?
The 52-week low for Jade Biosciences is $6.67. The current close of $19.95 is 199.1% above that low.
Does JBIO stock pay dividends?
Jade Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for JBIO?
Jade Biosciences's Debt / Equity ratio is 0.